While working on a postgraduate research project on ‘Pharmacovigilance in Africa’ through a grant from The University of Ferrara Italy and utilizing resources available at Queens University in New York, our founder Eric became increasingly aware that besides the safety concern of the drugs marketed in Africa, access and cost were major issues to address. The average life expectancy is 63 years mainly due to infant mortality and lack of management of chronic diseases like hypertension, diabetes and many others. One frequent
Upon completion of the research project he decided to complete pharmacy rotations and board examination to become a licensed pharmacist in the U.S. After years of working as a Pharmacist, he decided to redirect and focus his career towards pharmaceutical supply chain,
from production to commercialization in order to realize his vision of bridging the gap in pharmaceutical care and access between developing and developed countries.
Global Bridge Pharmaceutical was incorporated in Delaware with